WASHINGTON - Eligible Medicare beneficiaries can now obtain certain anti-obesity medications for $50 a month under a new ...

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

Millions could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.

By Mariam Sunny and Sneha S K July 1 (Reuters) - Millions of Americans are expected to gain coverage for GLP-1 drugs for ...

Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

The Centers for Medicare & Medicaid Services July 1 issued its calendar year 2027 proposed rule for the home health prospective payment system. The rule proposes a 2.4% update, which includes a 3.1% ...

The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...

Some Medicare beneficiaries could soon pay a flat $50 for GLP-1 drugs. Learn who qualifies, what employers may do, and what ...

Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” ...

BALTIMORE, Maryland, Nov. 15-- The U.S. Department of Health and Human Services' Centers for Medicare and Medicaid Services issued the following news release: The Centers for Medicare & Medicaid ...